| | Class 2 Device Recall MicroScan LabPro V5.0 |  |
| Date Initiated by Firm | October 05, 2026 |
| Date Posted | November 17, 2026 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-0472-2027 |
| Recall Event ID |
100090 |
| Product Classification |
Medical device data system - Product Code OUG
|
| Product | MicroScan LabPro V5.0 Maintenance Update 1 W/ Panel Update 09 DVD Kit (MR):
Catalog Number C82964 LabPro V5.0 Maintenance Update 1 W/ Panel Update 09
DVD Kit (MR)
Catalog C90384 LabPro V5.0 Maintenance Update 1 w/ Panel Update 09 (MR), Electronic |
| Code Information |
Catalog Number C82964 LabPro V5.0 Maintenance Update 1 W/ Panel Update 09
DVD Kit (MR)
Catalog C90384 LabPro V5.0 Maintenance Update 1 w/ Panel Update 09 (MR), Electronic |
| FEI Number |
2050012
|
Recalling Firm/ Manufacturer |
Beckman Coulter Inc.
250 S Kraemer Blvd
Brea
CA
92821-6232
|
| For Additional Information Contact | Kurtis Montegna 530-893-4333 |
Manufacturer Reason for Recall | Software defects that may affect antimicrobial susceptibility testing. |
FDA Determined Cause 2 | Software design |
| Action | On 10/5/2026, an "URGENT FIELD SAFETY NOTICE" Letter was sent via postal mail and/or email informing customers that, Beckman Coulter has identified software implementation errors in the products listed above which may affect antimicrobial susceptibility testing. Incorrect algorithms were implemented for Gram Positive Daptomycin, Gram Positive Clindamycin and Gram Positive Vancomycin, which may result in false susceptible or false resistant/ elevated MIC results when using instrument reads.
Customers are instructed to:
1. Manually verify results as shown below - Affected Assays, Instrument Reads, and Panel Part Numbers.
2. Continue routine quality control procedures, review flagged or unusual panel results and follow laboratory verification practices prior to reporting results.
3. Share the content of this letter with laboratory and/or medical director regarding the need to review previous patient test results.
4. Posting this letter on or near the affected analyzers.
|
| Quantity in Commerce | 1199 |
| Distribution | International distribution in the countries of Argentina, Bahrain, Belgium, Botswana, Brazil, Chile, Colombia, Czechia, Ecuador, France, Germany, Ghana, Greece, Guadeloupe, Hong Kong, India, Italy, Jordan, Kazakhstan, Korea Republic of, Kuwait, Martinique, Morocco, Namibia, Paraguay, Peru, Philippines, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, South Africa, Spain, Switzerland, Thailand, United Arab Emirates, United Kingdom of Great Britain and Northern Ireland, Uruguay, Vietnam. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
|
|
|